Safety and efficacy profile of bioresorbable-polylactide-polymer-biolimus-A9-eluting stents versus durable-polymer-everolimus- and zotarolimus-eluting stents in patients with acute coronary syndrome
详细信息 查看全文
- 作者：Milosz Jaguszewski ; Manuela Dö ; rig ; Antonio H. Frangieh ; Jelena-Rima Ghadri ; Victoria Lucia Cammann ; Johanna Diekmann ; L. Christian Napp ; Fabrizio D'Ascenzo ; Yoichi Imori ; Slayman Obeid ; Willibald Maier ; Thomas F. Lü ; scher and Christian Templin
- 刊名：Catheterization and Cardiovascular Interventions
- 出版年：2016
- 出版时间：15 November 2016
- 年：2016
- 卷：88
- 期：6
- 页码：E173-E182
- 全文大小：332K
- ISSN：1522-726X
文摘
Comparative data on long-term safety and efficacy of bioresorbable-polymer-BES versus durable-polymer-EES/ZES in ACS setting have hitherto been lacking. We sought to assess the safety and efficacy of bioresorbable-polymer-biolimus-A9-eluting stents (BES) compared with thin-strut-durable-polymer-everolimus- and zotarolimus-eluting stents (EES/ZES) in patients with acute coronary syndrome (ACS) undergoing PCI.